Randomized controlled trial of the impact on the outcome of pneumonia in children receiving Vitamin D supplementation

Jagadish K Jingi, Shailesh S Patil, Arunkumar S. Desai


Objective: To study whether vitamin D supplementation in children presenting with pneumonia and severe pneumonia reduce its duration of recovery. Study design: Randomized, Double blind, Placebo-controlled trial. Setting: Paediatric unit of a Teaching hospital. Methods: 80 children between 2 months-5 years with diagnosis of pneumonia and severe pneumonia (as per the WHO definition) admitted over a period of one year were included. Children with features of rickets, severe malnutrition, history of asthma, any underlying medical disorders and vitamin D supplementation over the last 12 months were excluded. Children were randomized to two groups, Intervention group received 300,000 IU of Vitamin D (1ml) and the control group received 1ml of Sterile water as a placebo intra muscularly along with antibiotics and supportive care. Children were monitored for the resolution of symptoms. The two groups were comparable for baseline demographic, socioeconomic, clinical and laboratory parameters. Results: There was no significant difference in time to resolution of symptoms (fever, tachypnea and chest retractions) in Intervention group (3.63±1.27 days) & placebo group (3.6±0.78 days), p=0.933). Conclusion: Supplementation of single high dose (300,000 IU) of vitamin D given intramuscularly have no beneficial effect on the resolution of pneumonia and severe pneumonia in the children of 2months to 5years of age.

Full Text:



Bryce J, Boschi-Pinto C, Shibuya K, Black RE; WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet. 2005 Mar 26-Apr 1; 365(9465):1147-52.

Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ. 2008;86:408-16.

Muhe L, Lulseged S, Mason K, Simoes E. Case-control study of the role of nutritional rickets in the risk of developing pneumonia in Ethiopian children. Lancet. 1997;349:1801-4.

Haugen J, Basnet S, Hardang I, Sharma A, Mathisen M, Shrestha P et al. Vitamin D status is associated with treatment failure and duration of illness in Nepalese children with severe pneumonia. Pediatr Res. 2017;82: 986-93.

Mc Nally J, Leis K, Matheson L, Karuanayake C. Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr Pulmonol. 2009; 44:981-8.

White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008 Sep; 76(9): 3837-43. doi: 10.1128/ IAI.00353-08. Epub 2008 May 27.

Wayse V, Yousafzai A, Mogale K, Filteau S. Association of Subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5y. Eur J Clin Nutr.2004;58:563-7.

Karatekin G, Kaya A, Salihoğlu O, Balci H, Nuhoğlu A. Association of subclinicalvitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr. 2009 Apr;63(4):473-7. Epub 2007 Nov 21.

Walker VP, Modlin RL. The vitamin D connection to pediatric infections and immune function. Pediatr Res. 2009 May; 65(5 Pt 2):106R-113R. doi: 10.1203/PDR. 0b013e31819dba91.

Sichert-Hellert W, Wenz G, Kersting M. Vitamin intakes from supplements and fortified food in German children & adolescents: results from the DONALD study. J Nutr.2006;136:1329-33.

Bhalala U, Desai M, Parekh P, Mokal R, Chheda B. Subclinicalhypovitaminosis D among exclusively breastfed younginfants. Indian Pediatr. 2007 Dec; 44 (12): 897-901.

Choudhary N, Gupta P. Vitamin Dsupplementation for severepneumonia--a randomized controlled trial. Indian Pediatr.2012Jun;49(6):449-54.Epub 2011Aug 15

Manaseki-Holland S, Qader G, Masher M, Bruce J, Mughal Z, Chandramohan D et al. Effects of Vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomized controlled trial. Trop Med Int Health. 2010;15:1148-55.

WHO (1995). The management of acute respiratory infections in children, Practical guidelines for outpatient care. World Health Organization.Geneva.

Park K. Park’s textbook of Preventive & Social Medicine, Ed.22. Jabalpur: M/S BANARSIDAS BHANOT; 2013.

Savitha MR, Nandeeshwara SB, Pradeep Kumar MJ, ul-Haque F, Raju CK. Modifiablerisk factors for acute lowerrespiratory tract infections. Indian J Pediatr. 2007 May;74(5):477-82.

Kutluk G, Chetinkaya F &Basak M. Comparisons of oral calcium, high dose vitamin D and a combination of these in the treatment of nutritional rickets in children. Journal of Tropical Pediatrics.2002;48:351-3.

Vieth R. Vitamin D supplementation, 25-hydroxy vitamin D concentrations, and safety. Am J ClinNutr. 1999 May; 69(5):842-56.

Yakoob Y, Salam A, Khan R, Bhutta A. Vitamin D supplementation for preventing infections in children under five years of age. Cochrane Database of Systematic Reviews. 2016;11. Art. No.: CD008824.


  • There are currently no refbacks.